Topical Corticosteroid App
NCT02921503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2018-08-15
Summary
The study aims to evaluate the effectiveness of a mobile application to assist in the prescription of topical corticosteroids (TCS), focusing on best fit choices of potency, vehicle and volume. The mobile application will be developed from the results obtained in a systematic literature review and quality assessment of clinical practice guidelines for topical corticosteroid use. The quality of the guidelines will be assessed using the AGREE II tool. After the app user enters in information concerning patients' rash location and desired treatment duration, the app will generate a list of recommended topical steroids (focusing on specific quantity and potency) for the patient's particular area of need. The objective of the study is to evaluate whether the use of a standardized application will change prescribing practices for primary care physicians, physician assistants and nurse practitioners.
Conditions
- Topical Corticosteroid, Topical, Medication, Utilization
Interventions
- OTHER
-
mobile topical corticosteroid app
app used on mobile phones that takes the input of providers and suggests topical corticosteroids with specific information on the ingredient, vehicle, and amount
Sponsors & Collaborators
-
Milton S. Hershey Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-05
- Primary Completion
- 2018-06-01
- Completion
- 2018-06-01
Countries
- United States
Study Locations
More Related Trials
-
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
NCT06702293 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff
NCT04495036 ·Status: COMPLETED
-
Characterization of Chronic Hand Eczema
NCT05026554 ·Status: RECRUITING
-
Efficacy of Targeted Intervention for Topical Steroid Phobia.
NCT03658252 ·Status: COMPLETED ·Phase: NA
-
Survey on Itch in Outpatients of a University Clinic
NCT03901443 ·Status: COMPLETED
-
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
NCT03352323 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Oral Steroids in the Treatment of Cellulitis
NCT00893048 ·Status: WITHDRAWN ·Phase: PHASE2
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparative Safety Study of New Sinecort Formulation Versus Positive Control
NCT00885937 ·Status: COMPLETED ·Phase: PHASE1
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Internet and Social Media Use in Dermatology Patients
NCT03913598 ·Status: COMPLETED
-
Allergy Skin Patch Artificial Intelligence (AI)
NCT05339750 ·Status: COMPLETED ·Phase: NA
-
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405 ·Status: UNKNOWN
-
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT05535738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT04955951 ·Status: TERMINATED
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2
-
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NCT04624867 ·Status: UNKNOWN ·Phase: PHASE1
-
Scratch Behavior Under Standard of Care
NCT03898427 ·Status: COMPLETED
-
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
NCT04853823 ·Status: UNKNOWN ·Phase: PHASE1
-
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
NCT02633371 ·Status: COMPLETED ·Phase: NA
-
Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)
NCT06551363 ·Status: COMPLETED
-
Cumulative Irritation Potential of 828 Ointment
NCT00767455 ·Status: COMPLETED ·Phase: PHASE1
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Contact Sensitization Potential of 828 Ointment
NCT00767676 ·Status: COMPLETED ·Phase: PHASE1